Friday, October 13, 2017 12:23:33 PM
What I mean by sequencing is the strategic completion of events and press releases in such a way that they have a synergistic effect and multiply on each other so that the combined sequence results in a higher valuation (in this case) than all of the same events and press releases would have if done separately. When looking at PPS/(availability of more company funds without much dilution) the goal would be to raise the market cap.
I think in this case OWCP is also fed up with the bottom feeders of the OTC world and likely to go to the NASDAQ sooner than some would think. Now I'm no expert but this is how I would like to see it played out.
TSX Listing
Published Results
JV Partnerships Announced
EU Exchange Listing
Products being sold
Revenue
Nasdaq listing
Patent Approvals
MM Study Orphan Drug Trial Submission/Approval
(After that I suspect we will have had 6 months or so worth of time to put into place the next sequence)
Some of these orders might be off from what actually happens but I think the goal would be to get more access to funds from other markets (with better regulations to keep our SEC monitoring us on the OTC) then drop big news to cement in a higher PPS.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM